|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 10 of 25 found articles
| Title: |
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China |
| Author: |
Wei, Jingxuan Xu, Kai Lin, Yingtao Liu, Qiang Zhou, Chongchong Zhang, Pei Ma, Rui Zhang, Mengdie Zhang, Lingli Li, Xin |
| Appeared in: |
International journal of clinical pharmacy |
| Paging: | Volume 46 () nr. 5 pages 1189-1199 |
| Year: |
2024-05-30 |
| Contents: | |
| Publisher: |
Springer International Publishing, Cham |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 10 of 25 found articles
| << previous | next >> |